Los Angeles Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-233,247	Closed	-$376K	–	1335
2025 Q1	$376K	Buy	233,247 +19,297	+9%	+$31.1K	﹤0.01%	827
2024 Q4	$270K	Buy	213,950 +42,770	+25%	+$53.9K	﹤0.01%	967
2024 Q3	$322K	Buy	+171,180	New	+$322K	﹤0.01%	986